)
Integra LifeSciences (IART) investor relations material
Integra LifeSciences Jefferies Global Healthcare Conference 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business overview and growth drivers
Operates in neurosurgery and regenerative medicine with two divisions: Specialty Surgery and Tissue Reconstruction.
Specialty Surgery targets a $6B market, holding top share positions in neurosurgery and instrumentation.
Tissue Reconstruction addresses a $2.5B market, leading in tissue reconstruction and offering biologics and synthetics for complex wounds.
90% of business is inpatient, with strong recurring demand and clinical evidence supporting products.
Relaunch of SurgiMend expected to accelerate growth and regain market share.
Leadership and strategic direction
Stuart Essig returned as CEO and Chairman effective May 1, bringing deep company knowledge.
No changes to ongoing transformation; focus remains on operational initiatives and execution.
Emphasis shifting from remediation to commercial readiness and customer engagement.
Execution is the top priority for the next several quarters.
Operational transformation and compliance
Launched a Compliance Master Plan in 2024 to strengthen quality management across 17 sites.
Centralized quality and supply chain efforts to improve efficiency and planning.
Most remediation activities to be completed by year-end, with improved supply chain visibility already evident.
Transformation is ongoing but showing positive early results.
- Transformation progress, product relaunches, and operational gains set the stage for renewed growth.IART
Bank of America Global Healthcare Conference 202619 May 2026 - Q1 revenue and EPS beat guidance, with raised EPS outlook and ongoing transformation progress.IART
Q1 202611 May 2026 - Dr. Stuart M. Essig named President and CEO; board reduced to seven after Ms. Poul's departure.IART
Proxy filing5 May 2026 - 2026 guidance projects modest growth and margin gains despite a large 2025 goodwill impairment.IART
Q4 20259 Apr 2026 - Proxy details transformation, governance, pay-for-performance, and key proposals for 2026.IART
Proxy filing6 Apr 2026 - Q2 revenue up 9.7% to $418.2M, but net loss and compliance costs lower 2024 outlook.IART
Q2 20242 Feb 2026 - Shipping holds, facility expansion, and compliance investments shape near-term outlook.IART
Wells Fargo 2024 Healthcare Conference22 Jan 2026 - Compliance and supply issues are being addressed, positioning for resumed growth in 2025.IART
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Compliance initiatives, product relaunches, and innovation set the stage for future growth.IART
CL King's 22nd Annual Best Ideas Conference 202420 Jan 2026
Next Integra LifeSciences earnings date
Next Integra LifeSciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)